Marie's disease

2021 Insights on the Ankylosing Spondylitis Global Market - Identify Target Patient Population - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 13, 2021

b'The "Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides Ankylosing Spondylitis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides Ankylosing Spondylitis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Ankylosing Spondylitis patients, history of the disease at the population level (Ankylosing Spondylitis prevalence, Ankylosing Spondylitis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Ankylosing Spondylitis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Ankylosing Spondylitis market sizing, assessing market potential, and developing drug forecast models\nIdentify Ankylosing Spondylitis patients segments through age groups, gender, and disease sub-types\nEvaluate Ankylosing Spondylitis market opportunities, identify target patient population\n'

Global Ankylosing Spondylitis (Bekhterev's Disease) Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 11, 2021

Axial SpA is further divided into two subgroups as Ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA).\nThe disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalence of Ankylosing Spondylitis, Diagnosed Prevalence of Ankylosing Spondylitis, Gender-specific Diagnosed Prevalence of Ankylosing Spondylitis, Age-specific Diagnosed Prevalence of Ankylosing Spondylitis, and Gene-specific Diagnosed Prevalence of Ankylosing Spondylitis scenario in the United States from 2018 to 2030.\nThe total prevalent population of Ankylosing Spondylitis (AS) in the US is anticipated to rise from 2018 to 2030.

Key Points: 
  • Axial SpA is further divided into two subgroups as Ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA).\nThe disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalence of Ankylosing Spondylitis, Diagnosed Prevalence of Ankylosing Spondylitis, Gender-specific Diagnosed Prevalence of Ankylosing Spondylitis, Age-specific Diagnosed Prevalence of Ankylosing Spondylitis, and Gene-specific Diagnosed Prevalence of Ankylosing Spondylitis scenario in the United States from 2018 to 2030.\nThe total prevalent population of Ankylosing Spondylitis (AS) in the US is anticipated to rise from 2018 to 2030.
  • The prevalent cases are expected to increase at a CAGR of 0.97% for the study period of 2018-2030.\nThe prevalent population of Ankylosing Spondylitis (AS) showed a male predominance.
  • Additionally, there are no specific lab tests to identify ankylosing spondylitis.
  • Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.\n3 Disease Background and Overview: Ankylosing Spondylitis (AS)\n'